Juno Therapeutics jumps 53% after report Celgene is interested in buying the cancer drugmaker

NOW WATCH: Money & Markets videos

Business Insider Emails & Alerts

Site highlights each day to your inbox.

Follow Business Insider Australia on Facebook, Twitter, LinkedIn, and Instagram.